다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Vir Biotechnology Inc (VIR)
Vir Biotechnology Inc (VIR) 뉴스

VIR

Vir Biotechnology (VIR)

Vir Biotechnology Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VIR

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/28	02:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/27	20:01	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/27	06:23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/27	06:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/27	06:05	Business Wire	Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/26	05:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/26	05:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/26	05:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/26	05:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/26	05:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/26	05:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/25	10:57	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/25	10:56	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/25	10:40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/25	10:38	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/20	06:05	Business Wire	Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/15	08:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/14	08:49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VIR	Vir Biotechnology Inc
2025/02/13	06:05	Business Wire	Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025	NASDAQ:VIR	Vir Biotechnology Inc
2025/01/30	21:51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIR	Vir Biotechnology Inc
2025/01/08	21:50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VIR	Vir Biotechnology Inc
2025/01/08	21:45	Business Wire	Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC	NASDAQ:VIR	Vir Biotechnology Inc
2024/12/18	23:30	Business Wire	Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:VIR	Vir Biotechnology Inc
2024/12/13	06:05	Business Wire	Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta	NASDAQ:VIR	Vir Biotechnology Inc
2024/12/05	05:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VIR	Vir Biotechnology Inc
2024/12/03	07:08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VIR	Vir Biotechnology Inc
2024/11/26	23:30	Business Wire	Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN™ Masked T-Cell Engager Programs	NASDAQ:VIR	Vir Biotechnology Inc
2024/11/25	23:30	Business Wire	Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference	NASDAQ:VIR	Vir Biotechnology Inc
2024/11/19	11:15	Business Wire	Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program	NASDAQ:VIR	Vir Biotechnology Inc
2024/11/19	06:05	Business Wire	Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency	NASDAQ:VIR	Vir Biotechnology Inc

검색 관련기사 보기:NASDAQ:VIR

1 2 3 4 5 6 7 8 9 10 다음 >>

First Trust Japan AlphaDEX

Thames River Multi Hedge Pcc

Kiniksa Pharmaceuticals

Tetra Bio Pharma

Rep. Kaz 1.55%s

Total USD Bond Market ETF

Vontobel Financial Produ...

Honat Bancorp (PK)

ProShares Ultra NASDAQ B...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관